In this episode of Biology Career Insights, we sit down with Patrick Bongartz, Co-Founder and CEO of BioThrust, a biotech startup revolutionizing cell culture processes with its patented bubble-free, low-shear bioreactor technology.Patrick takes us through his inspiring journey—from his academic foundation at RWTH Aachen University to founding BioThrust in 2020, and how he and his co-founders tackled key challenges in bioprocessing. We talk about the technical innovation behind their ComfyCell system, the evolution of cell and gene therapy, and what it means to build a startup in today’s complex biotech landscape.This candid conversation covers:Patrick’s academic and entrepreneurial backgroundThe story and mission behind BioThrustDeep dive into bioprocessing innovation: bubble-free aerationTrends in MSC, CAR-T, and HEK scale-upInsights from ISCT and ASGCT 2025 conferencesReflections on co-founder dynamics, fundraising, and navigating uncertainty in biotechAdvice for aspiring scientists and biotech entrepreneurs✨ A huge thanks to Patrick for generously sharing his story and insights!🔔 Subscribe for more conversations with biotech leaders: https://youtube.com/@bcipodcast

📩 Learn more or get in touch: www.bcipodcast.eu

In the biotech world, flashy ads just don’t cut it. Scientists, researchers, and decision-makers aren’t persuaded by slogans—they’re influenced by evidence, insight, and authentic expertise.That’s why educational content isn’t just a nice-to-have—it’s the most effective marketing strategy in biotech today.In this video, we explore how formats like:🎙️ Podcasts✍️ Blog Posts📢 Webinars...offer far more than visibility. They:Build trust by speaking the language of data and discoveryPosition your brand as a thought leader, not just a vendorCreate lasting engagement with communities that care about why, not just what✅ It's time to sell less and teach more.If you’re still chasing clicks instead of building credibility, it’s time to rethink your biotech marketing playbook.👉 How are you using educational content to lead with value?🔔 Subscribe for more insights on content strategy, science communication, and building brand authority in the biotech space.#BiotechMarketing #ContentStrategy #STEMMarketing #ThoughtLeadership #PodcastMarketing #ScienceCommunication #B2BMarketing #EducationalContent

In this episode we discuss a breakthrough in organoid research by Stanford Medicine scientists, who successfully created heart and liver organoids with their own functional blood vessel systems. Traditionally, organoids have been limited in size due to their inability to receive oxygen and nutrients, but this new development allows for larger, more mature organoids that better mimic human organs. These vascularized organoids hold significant promise for advancing research into human development and disease, as well as paving the way for future regenerative therapies, such as implantable tissue grown from a patient's own stem cells. The research involved optimizing chemical "recipes" to reliably produce the necessary cell types for blood vessel formation, demonstrating a successful method that could be applied to other organoid types.